Krystal Biotech (KRYS) News Today $138.54 -23.75 (-14.63%) As of 03:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by First Trust Advisors LPFirst Trust Advisors LP trimmed its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 41.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,169 shares of the company's stock after selling 16,242May 5 at 3:44 AM | marketbeat.comChardan Capital Predicts Lower Earnings for Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities research analysts at Chardan Capital lowered their FY2025 earnings estimates for shares of Krystal Biotech in a report issued on Tuesday, April 29th. Chardan Capital analyst Y. Livshits now anticipates that the company will post earningMay 4 at 8:11 AM | marketbeat.comFY2026 EPS Estimates for Krystal Biotech Lifted by AnalystKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - HC Wainwright raised their FY2026 earnings per share estimates for shares of Krystal Biotech in a note issued to investors on Monday, April 28th. HC Wainwright analyst J. Pantginis now forecasts that the company will earn $6.30 per share for theMay 3 at 8:54 AM | marketbeat.comAquatic Capital Management LLC Invests $1.08 Million in Krystal Biotech, Inc. (NASDAQ:KRYS)Aquatic Capital Management LLC acquired a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,901 shares of the company's stock, valued at apprMay 3 at 5:09 AM | marketbeat.comKrystal Biotech FY2025 EPS Forecast Cut by Chardan CapitalMay 3 at 2:51 AM | americanbankingnews.comNebula Research & Development LLC Decreases Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Nebula Research & Development LLC reduced its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 43.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,670 shares of the company's stock after selling 2,035 shares during the quarter. Nebula ResMay 2, 2025 | marketbeat.comHC Wainwright Expects Stronger Earnings for Krystal BiotechMay 2, 2025 | americanbankingnews.comKrystal Biotech (KRYS) Expected to Announce Quarterly Earnings on TuesdayKrystal Biotech (NASDAQ:KRYS) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-krystal-biotech-inc-stock/)May 1, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Holdings Boosted by Voya Investment Management LLCVoya Investment Management LLC grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 74,701 shares of the company's stock after purchasing an additional 4,123 sMay 1, 2025 | marketbeat.comDimensional Fund Advisors LP Cuts Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Dimensional Fund Advisors LP lowered its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 588,599 shares of the company's stock aMay 1, 2025 | marketbeat.comMarshall Wace LLP Makes New $1.62 Million Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)Marshall Wace LLP purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 10,331 shares of the company's stock, valued at approximatelyMay 1, 2025 | marketbeat.comDemystifying Krystal Biotech: Insights From 7 Analyst ReviewsMay 1, 2025 | nasdaq.comKrystal Biotech's Vyjuvek gains European approval for rare skin disease treatmentMay 1, 2025 | bizjournals.comKrystal Biotech (NASDAQ:KRYS) Price Target Raised to $240.00HC Wainwright increased their target price on Krystal Biotech from $221.00 to $240.00 and gave the stock a "buy" rating in a research report on Monday.April 30, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Increases Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Price T Rowe Associates Inc. MD increased its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 16.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 509,459 shares of the company's stock after buApril 30, 2025 | marketbeat.comUS FDA approves first cell-based gene therapy for rare genetic skin disorderApril 29, 2025 | msn.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC decreased its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 24.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,900 shares of the company's stock after selling 3,500 shares duApril 29, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for Krystal Biotech (NASDAQ:KRYS) StockApril 29, 2025 | americanbankingnews.comKrystal Biotech gets EU approval for VyjuvekApril 29, 2025 | msn.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Purchased by Decheng Capital LLCDecheng Capital LLC increased its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 7.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 76,772 shares of the company's stock after buying an additional 5,000 shares during the period. Krystal BiApril 28, 2025 | marketbeat.comKrystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis BullosaApril 28, 2025 | globenewswire.comLord Abbett & CO. LLC Sells 68,531 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Lord Abbett & CO. LLC reduced its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 24.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 215,628 shares of the company's stock after selling 68,531 shares durinApril 28, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by LPL Financial LLCLPL Financial LLC increased its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 156.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,946 shares of the company's stock after buying aApril 28, 2025 | marketbeat.comTower Research Capital LLC TRC Raises Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Tower Research Capital LLC TRC raised its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 7,944.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,999 shares of the company's stockApril 27, 2025 | marketbeat.comWells Fargo & Company MN Boosts Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Wells Fargo & Company MN boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 21.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,928 shares of the company's stock afterApril 27, 2025 | marketbeat.comXTX Topco Ltd Acquires Shares of 2,102 Krystal Biotech, Inc. (NASDAQ:KRYS)XTX Topco Ltd bought a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 2,102 shares of the company's stock, valued at approximately $329,000. Several other hedge funds andApril 26, 2025 | marketbeat.comBarclays PLC Sells 4,111 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Barclays PLC trimmed its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 7.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 52,429 shares of the company's stock after selliApril 26, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Hood River Capital Management LLCHood River Capital Management LLC boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 2.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 512,726 shares of the company's stock after purchasing an additional 10,622 sharApril 25, 2025 | marketbeat.comTD Cowen Sticks to Its Buy Rating for Krystal Biotech (KRYS)April 24, 2025 | markets.businessinsider.comPittsburgh biotech firms benefit in potential pharma tariffs and domestic manufacturing shiftApril 24, 2025 | bizjournals.comKrystal Biotech to Present at Upcoming Scientific ConferencesApril 24, 2025 | globenewswire.comIBD Rating Upgrades: Krystal Biotech Flashes Improved Relative Price StrengthApril 23, 2025 | msn.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Avoro Capital Advisors LLC's 5th Largest PositionAvoro Capital Advisors LLC increased its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 0.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,628,822 shares of the company's stock after buyApril 23, 2025 | marketbeat.com102,061 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 102,061 shares of the company's stock, valued at apApril 23, 2025 | marketbeat.comS Squared Technology LLC Acquires 20,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)S Squared Technology LLC raised its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 26.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 95,215 shares of the company's stock after acquirApril 19, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Position Reduced by Invesco Ltd.Invesco Ltd. reduced its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 24.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 275,195 shares of the company's stock after selling 90,356 shares dApril 19, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Krystal Biotech (KRYS)April 18, 2025 | markets.businessinsider.comFate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT TagApril 15, 2025 | msn.comKennedy Capital Management LLC Grows Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Kennedy Capital Management LLC boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 433.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,711 shares of the company's stock after acquiring an additional 22April 15, 2025 | marketbeat.comAbeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Long-Term UpsideApril 14, 2025 | seekingalpha.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Evolutionary Tree Capital Management LLCEvolutionary Tree Capital Management LLC raised its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 17.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,700 shares of the company's stock afterApril 14, 2025 | marketbeat.comCenterBook Partners LP Buys Shares of 4,283 Krystal Biotech, Inc. (NASDAQ:KRYS)CenterBook Partners LP bought a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 4,283 shares of the company's stock, valued at approxiApril 14, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of "Buy" from AnalystsKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been assigned an average recommendation of "Buy" from the eight ratings firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has iApril 13, 2025 | marketbeat.comExodusPoint Capital Management LP Buys Shares of 9,761 Krystal Biotech, Inc. (NASDAQ:KRYS)ExodusPoint Capital Management LP bought a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 9,761 shares of the company's stock, valued at approximately $1,529,000. Other largeApril 12, 2025 | marketbeat.comJPMorgan Chase & Co. Buys 23,934 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)JPMorgan Chase & Co. grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 18.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 151,835 shares of the company's stock afterApril 12, 2025 | marketbeat.comFmr LLC Increases Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Fmr LLC grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 0.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,314,014 shares of the company's stock after purApril 11, 2025 | marketbeat.comOLD Mission Capital LLC Buys Shares of 1,868 Krystal Biotech, Inc. (NASDAQ:KRYS)OLD Mission Capital LLC bought a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,868 shares of the company's stock, valued at aApril 9, 2025 | marketbeat.comKrystal Biotech, Inc.: Jeune Aesthetics Appoints Marc Forth as Chief Executive OfficerApril 8, 2025 | finanznachrichten.deKrystal Biotech’s Jeune Aesthetics names Marc Forth as CEOApril 8, 2025 | markets.businessinsider.comKrystal Biotech Q1 EPS Forecast Reduced by William BlairKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Analysts at William Blair reduced their Q1 2025 EPS estimates for Krystal Biotech in a research report issued to clients and investors on Wednesday, April 2nd. William Blair analyst S. Corwin now anticipates that the company will post earnings pApril 8, 2025 | marketbeat.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼0.880.69▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼216▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News TEVA News ITCI News GMAB News RDY News MRNA News ASND News VTRS News QGEN News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredConfidential Economic AdvisoryI've hesitated for months to record this video. The very act of sharing these details makes me deeply uncom...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRYS Stock Free KRYS Stock Alerts